Sara Schad, Ph.D

Associate, Research

Headshot photo of Sara Schad, Ph.D

Dr. Schad joined Cowen Healthcare Investments in October 2021 and researches novel therapeutic and diagnostic approaches employed by biotechnology and healthcare companies.

Dr. Schad received her Ph.D. in Immunology and Microbial Pathology from Weill Cornell Graduate School of Medical Sciences, where her work was focused on identifying and characterizing novel T cell phenotypes within the tumor microenvironment.  Dr. Schad holds a BS in Biology from the College of William and Mary where she studied mechanisms of nuclear translocation. She also spent time at Dana Farber Cancer Institute researching novel immunotherapy targets and consulted for a healthcare focused hedge fund based out of San Francisco.

Get In Touch

Start a conversation with Sara Schad, Ph.D

Investment Management Team

Our team of dedicated investment professionals seek to capitalize on disruption and dislocation across market, geographies and sectors.

View More
Investment management professional reviews report with a client